Of particular note, SMAD4 deficiency accelerated transformation in EGFR-wildtype, TP53-deficient NSCLC cells, suggesting that alternative molecular routes can drive neuroendocrine differentiation in the absence of EGFR mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.